Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06418022 · ClinicalTrials.gov registry record · NA
Evaluating Fluid Responsiveness in ICU Patients Using VTI and Trendelenburg Positioning
A NA study of Shock and Fluid Overload, sponsored by Lenox Hill Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 1
- Study location
NCT06418022 is a NA study of Shock and Fluid Overload that is actively recruiting participants, run by Lenox Hill Hospital. The registered enrollment target is 400 participants, roughly in line with the 437-participant average among 9 other Shock trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT06418022, a NA study of Shock and Fluid Overload, is actively recruiting participants, sponsored by Lenox Hill Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
Fluid administration is a commonly performed in the ICU for critically ill patients. However, it can lead to complications such as fluid overload, pulmonary edema, and increased mortality in some patients. Therefore, identifying patients who are likely to respond to fluid therapy is crucial for optimizing their management. Several methods have been used to assess fluid responsiveness, such as passive leg raising, stroke volume variation, and cardiac output monitoring. However, these methods have limitations and may not be feasible in all patients. In this study, the investigators aim to evaluate the use of velocity time integral (VTI) and Trendelenburg positioning in predicting fluid responsiveness in ICU patients.
Conditions Studied
Interventions
- DEVICE Trendelenburg positioning VTI
Study Locations (1)
New York
- Lenox Hill Hospital- Northwell Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2024-04-01 |
| Est. Completion | 2025-08-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06418022
The ClinicalTrials.gov registry entry for NCT06418022 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 437-participant average among 9 other Shock trials with a reported enrollment target. The listed sponsor is Lenox Hill Hospital, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Shock appearing as the primary indexed condition, and to 1 intervention - of which Trendelenburg positioning VTI is the first listed.
NCT06418022 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06418022 about?
NCT06418022 is a clinical study titled "Evaluating Fluid Responsiveness in ICU Patients Using VTI and Trendelenburg Positioning". Fluid administration is a commonly performed in the ICU for critically ill patients. However, it can lead to complications such as fluid overload, pulmonary edema, and increased mortality in some patients. Therefore, identifying patients who are likely to respond to fluid therapy is crucial for opti...
What is the current status of trial NCT06418022?
This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2024-04-01. Estimated completion is 2025-08-01.
What conditions does trial NCT06418022 study?
This clinical trial studies the following conditions: Shock, Fluid Overload, Cardiac Output, Low.
What interventions are being tested in trial NCT06418022?
The interventions under investigation include: Trendelenburg positioning VTI (DEVICE).
Who is sponsoring clinical trial NCT06418022?
This trial is sponsored by Lenox Hill Hospital, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06418022 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Shock
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Augmented Pacing for Shock in the Cardiac Intensive Care Unit
RECRUITING · NA
-
Assessment of Stroke Volume in Shock Using Echocardiography Versus Bioreactive Impedance
RECRUITING
-
Resuscitative TEE Collaborative Registry
RECRUITING
-
Central Line Study
RECRUITING · Phase 4
-
Vasoactive Drugs in Intensive Care Unit
RECRUITING · Phase 4
-
Hemodynamic Response to Angiotensin-II When Used as the Second Vasopressor Agent for Septic Shock
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.